Advanced search
Publication Cover
Current Medical Research and Opinion Volume 35, 2019 - Issue 10
Submit an article Journal homepage
720
Views
17
CrossRef citations to date
0
Altmetric
Pain

Efficacy and safety of mirogabalin for the treatment of fibromyalgia: results from three 13-week randomized, double-blind, placebo- and active-controlled, parallel-group studies and a 52-week open-label extension study

Lesley M. ArnoldWomen’s Health Research Program, University of Cincinnati College of Medicine, Cincinnati, OH, USA;
,
Susan WhitakerDaiichi Sankyo Inc., Basking Ridge, NJ, USA;
,
Ching HsuDaiichi Sankyo Inc., Basking Ridge, NJ, USA;
,
David JacobsDaiichi Sankyo Inc., Basking Ridge, NJ, USA;
&
Domenico MeranteGlobal Clinical Development, Daiichi Sankyo Development, Gerrards Cross, United KingdomCorrespondence[email protected]
Pages 1825-1835 | Received 01 Apr 2019, Accepted 04 Jun 2019, Published online: 09 Jul 2019

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Roland Staud. (2022) Advances in the management of fibromyalgia: what is the state of the art?. Expert Opinion on Pharmacotherapy 23:8, pages 979-989.
Read now
Takahiro Ushida, Mizuka Yokoyama, Kazuhito Shiosakai, Kengo Saito, Shigehisa Ibe & Kaoru Okuizumi. (2022) A large-scale database study for the prescription status of a new voltage-gated Ca2+ channel α2δ ligand, mirogabalin, in Japan. Expert Opinion on Pharmacotherapy 23:2, pages 273-283.
Read now
Xiao Zhang, Huji Xu, Zhiyi Zhang, Yang Li, Lynne Pauer, Shanmei Liao & Fengchun Zhang. (2021) Efficacy and Safety of Pregabalin for Fibromyalgia in a Population of Chinese Subjects. Journal of Pain Research 14, pages 537-548.
Read now
Marie Selvy, Mélissa Cuménal, Nicolas Kerckhove, Christine Courteix, Jérôme Busserolles & David Balayssac. (2020) The safety of medications used to treat peripheral neuropathic pain, part 1 (antidepressants and antiepileptics): review of double-blind, placebo-controlled, randomized clinical trials. Expert Opinion on Drug Safety 19:6, pages 707-733.
Read now
Domenico Merante. (2020) The mirogabalin ALDAY phase 3 program in pain associated with fibromyalgia: the lessons learned. Current Medical Research and Opinion 36:4, pages 661-666.
Read now

Articles from other publishers (12)

Pothuri R Ram, Madhan Jeyaraman, Naveen Jeyaraman, Arulkumar Nallakumarasamy, Manish Khanna, Ashim Gupta & Sankalp Yadav. (2023) Beyond the Pain: A Systematic Narrative Review of the Latest Advancements in Fibromyalgia Treatment. Cureus.
Crossref
Takahiro Ushida, Yoichi Katayama, Yoichi Hiasa, Makoto Nishihara, Fumihiro Tajima, Shinsuke Katoh, Hirotaka Tanaka, Takeshi Maeda, Kazunari Furusawa, Yoshihiro Kakehi, Kunika Kikumori & Masanori Kuroha. (2023) Long-Term Safety and Efficacy of Mirogabalin for Central Neuropathic Pain: A Multinational, Phase 3, 52-Week, Open-Label Study in Asia. Pain and Therapy 12:4, pages 963-978.
Crossref
Hui Tang, Jing Lu, Yazhuo Duan & Dejun Li. (2023) The Clinical Application and Progress of Mirogabalin on Neuropathic Pain as a Novel Selective Gabapentinoids. Mediators of Inflammation 2023, pages 1-13.
Crossref
Abhijit Nair. (2022) Mirogabalin, a selective gabapentinoid for managing neuropathic pain—A curtain raiser. Journal of Anaesthesiology Clinical Pharmacology 38:4, pages 691.
Crossref
Eric Y. Chen, Sascha S. Beutler, Alan D. Kaye, Amber N. Edinoff, Seyed-Hossein Khademi, Andrea E. Stoltz, Nicole R. Rueb, Elyse M. Cornett & Winston J. Suh. (2021) Mirogabalin as a Novel Gabapentinoid for the Treatment of Chronic Pain Conditions: An Analysis of Current Evidence. Anesthesiology and Pain Medicine 11:6.
Crossref
Abhijit Nair, Subodh Kamtikar & Suresh Seelam. (2021) Safety, tolerability, and efficacy of a selective gabapentinoid mirogabalin in neuropathic pain—a topical review. Ain-Shams Journal of Anesthesiology 13:1.
Crossref
Renata Zajączkowska, Joanna Mika, Wojciech Leppert, Magdalena Kocot-Kępska, Małgorzata Malec-Milewska & Jerzy Wordliczek. (2021) Mirogabalin—A Novel Selective Ligand for the α2δ Calcium Channel Subunit. Pharmaceuticals 14:2, pages 112.
Crossref
Jae-Yeon Kim, Salahadin Abdi, Billy Huh & Kyung-Hoon Kim. (2021) Mirogabalin: could it be the next generation gabapentin or pregabalin?. The Korean Journal of Pain 34:1, pages 4-18.
Crossref
Shuji Komatsu, Shingo Nakamura, Takahiro Nonaka, Toshihiko Yamada & Tatsuo Yamamoto. (2021) Analgesic characteristics of a newly developed α 2 δ ligand, mirogabalin, on inflammatory pain . Molecular Pain 17, pages 174480692110521.
Crossref
Emma Guymer & Geoffrey Littlejohn. 2021. Fibromyalgia Syndrome. Fibromyalgia Syndrome 33 52 .
Rodrigo Oliveira Mascarenhas, Mateus Bastos Souza, Murilo Xavier Oliveira, Ana Cristina Lacerda, Vanessa Amaral Mendonça, Nicholas Henschke & Vinícius Cunha Oliveira. (2021) Association of Therapies With Reduced Pain and Improved Quality of Life in Patients With Fibromyalgia. JAMA Internal Medicine 181:1, pages 104.
Crossref
Roie Tzadok & Jacob N. Ablin. (2020) Current and Emerging Pharmacotherapy for Fibromyalgia. Pain Research and Management 2020, pages 1-9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.